在医疗保险受益者中诊断出轻度认知障碍的患病率和预测因素
Elyse Couch1, Munachimso Ugoh1, Lauren Thomas1
1Department of Health Services, Policy and Practice Brown University School of Public Health Providence Rhode Island USA.
Alzheimer's & dementia (Amsterdam, Netherlands)
|December 31, 2025
概括
只有10.6%的Medicare受益者有轻度认知障碍 (MCI) 症状得到诊断. 妇女和那些有高等教育的人更有可能被诊断出MCI,突出需要提高MCI检测率.
科学领域:
- 老年学是一门学科.
- 神经学 神经学
- 公共卫生 公共卫生
背景情况:
- 轻度认知障碍 (MCI) 是痴呆症的一个重要风险因素.
- 早期诊断MCI允许及时干预和规划.
- 在医疗保险受益者中,MCI诊断率在很大程度上是未知的.
研究的目的:
- 为了确定在医疗保险受益者中诊断出MCI的患病率.
- 在这个人群中确定与MCI诊断相关的因素.
主要方法:
- 利用了与医疗保险索赔 (2014-2022) 相关的国家健康和衰老趋势研究 (NHATS) 的数据.
- 使用NHATS算法定义MCI,并通过ICD代码识别诊断.
- 使用后勤回归来分析MCI诊断的预测因素.
主要成果:
- 10.6%的患有MCI症状的医疗保险受益者有记录的MCI诊断.
- 在女性和拥有学士学位或更高学历的人群中,诊断的几率更高.
- 诊断的几率较低与仅仅看病的医生访问有关.
结论:
- 医疗保险受益者当前的MCI诊断率很低.
- 有针对性的策略对于加强MCI检测至关重要.
- 鉴于MCI治疗和诊断方面的进展,改善诊断是至关重要的.
更多相关视频
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
33.7K
06:58Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
7.7K
相关概念视频
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Cognitive Development During Adulthood
740
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
740
Dementia
482
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
482
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
503
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
503
Drug Dosing: Geriatric Patients
206
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
206
